Material Type

• Blood (whole) (3)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (single spun) (6)
• Saliva (3)
• Serum (5)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (6)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (5)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (6)
• Followup records (5)
• Freezer temperature logs (3)
• Imaging data (1)
• Microbiological results (3)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (3)
• Pre-analytical data (5)
• Primary care records (1)
• Quality indicators (5)
• Survey data (2)
• Treatment records (2)

Timeframe

• Immediate (3)
• 0 - 3 months (4)
• 3 - 6 months (1)
• > 6 months (3)

Participant Count

• 11 - 100 (2)
• 101 - 500 (3)
• 1001 - 3000 (1)
• 10001 - 50000 (1)

Sex

• Both sexes (6)

Age Range

• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (5)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (3)
• Cell culture (1)
• Data analytics (4)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Disease specific (4)
• Longitudinal (1)
• Population-based (1)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (6)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (4)
• No restrictions (0)
• No Project specific restriction (6)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (4)

Access Condition

• Open to applicants (4)
• Open only through collaboration (1)
• Access restricted at present (1)

Country

• Brazil (1)
• France (1)
• Peru (1)
• South Africa (1)
• Uganda (1)
• United States (1)

County